Immunomatrix

ImmunoMatrix is a clinical-stage biotechnology company based in South Korea that specializes in the development of innovative microneedle-based drug delivery systems. The company's proprietary platform focuses on dissolving and solid microneedles designed to deliver vaccines and biopharmaceuticals through the skin, targeting the dermis's high concentration of immune cells. By utilizing this intradermal route, ImmunoMatrix aims to enhance the immune response, reduce the required dose of active ingredients, and eliminate the need for traditional needle-and-syringe administration. Their lead program, a microneedle-delivered Hepatitis B vaccine, has entered clinical trials, supported by collaborations with global health organizations like PATH. The technology also offers advantages in terms of thermal stability, potentially reducing the reliance on cold-chain logistics for vaccine distribution in developing regions.